InvestorsHub Logo
Followers 22
Posts 4023
Boards Moderated 0
Alias Born 10/12/2013

Re: NickHous post# 175715

Monday, 02/11/2019 4:48:17 PM

Monday, February 11, 2019 4:48:17 PM

Post# of 424049

The agency rolls out part of its plan Monday by sending warning letters to 17 companies for "illegally selling" products that claim to treat Alzheimer's disease.
It's also creating the Botanical Safety Consortium, a partnership between the public and private sectors, to evaluate the safety of botanical ingredients and mixtures in supplements




I think there is a ways to go before they get to GNC/Costco/Rexall "fish oil" over purity or QC issues. High concentration/claimed high purity EPA might be a different matter once V has the Reduce It indication, depending on DS/drug issues or claims for CVD treatment. Amarin's/FDA's effectiveness will be a matter of resources applied and the video I saw on emergency room visits from DS didn't seem to indicate fish oil as a significant part of the problem that's drawn their attention...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News